Leerink Partners analyst Thomas Smith has reiterated their bullish stance on RNAC stock, giving a Buy rating yesterday.Invest with Confidence: ...
1, Jerry Kelly, 88.89%. 2 (tie), Steven Alker, Alex Cejka and Steve Flesch, 87.04%. 5 (tie), Ernie Els, Mark Hensby, Thongchai Jaidee and Bernhard Langer, 85.19%. 9, Ken Tanigawa, 83.33%. 10, Brett ...
Mitchell Kapoor, an analyst from H.C. Wainwright, reiterated the Buy rating on Cartesian Therapeutics (RNAC – Research Report). The associated ...
Julian Harrison, an analyst from BTIG, reiterated the Buy rating on Cartesian Therapeutics (RNAC – Research Report). The associated price ...
The University of Wyoming lists the following students from Wyoming on the 2024 fall semester President’s Honor Roll.
2d
In a report released today, Gil Blum from Needham maintained a Buy rating on Cartesian Therapeutics (RNAC – Research Report), with a price ...
The raised price target to $69 from $64 by Guggenheim reflects the firm's heightened confidence in Sphere Entertainment's ...
As Sundance Film Festival kicks off, the next major American film festival has unveiled its lineup. SXSW 2025's slate includes the premieres of the latest films from Michael Bay, Chad Hartigan, Flying ...
Cleveland's extreme cold weather this week resulted in some weather-related injuries, along with burst pipes and other fall ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback